Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model.
In conclusion, human iPSC-derived liver organoids can be safely transplanted through the portal vein. Ligation of the ductus venosus prior to transplantation was effective in inhibiting extrahepatic translocation in newborns and infants.
PMID: 33103476 [PubMed - in process]
Source: Cell Transplantation - Category: Cytology Authors: Tsuchida T, Murata S, Hasegawa S, Mikami S, Enosawa S, Hsu HC, Fukuda A, Okamoto S, Mori A, Matsuo M, Kawakatsu Y, Matsunari H, Nakano K, Nagashima H, Taniguchi H Tags: Cell Transplant Source Type: research
More News: Brain | Clinical Trials | Cytology | Hypertension | Liver | Liver Disease | Liver Transplant | Lung Transplant | Neurology | Stem Cell Therapy | Stem Cells | Translocation | Transplant Surgery | Transplants | Urology & Nephrology